Valentin Blanchard

750 total citations
25 papers, 533 citations indexed

About

Valentin Blanchard is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Valentin Blanchard has authored 25 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Valentin Blanchard's work include Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (6 papers). Valentin Blanchard is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (6 papers). Valentin Blanchard collaborates with scholars based in France, Réunion and Canada. Valentin Blanchard's co-authors include Gilles Lambert, Kévin Chemello, Mikaël Croyal, Stéphane Ramin‐Mangata, Brice Nativel, Gordon A. Francis, Bertrand Cariou, Jean‐Pierre Henry, M.F. Isambert and Rita Raisman‐Vozari and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Lipid Research and Diabetologia.

In The Last Decade

Valentin Blanchard

24 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Valentin Blanchard France	15	313	138	136	121	86	25	533
Bradley McEvoy United States	5	205 0.7×	222 1.6×	213 1.6×	140 1.2×	298 3.5×	13	726
Eyas Raddad United States	12	101 0.3×	123 0.9×	195 1.4×	37 0.3×	28 0.3×	21	602
Anna Helgadóttir Iceland	10	123 0.4×	60 0.4×	241 1.8×	64 0.5×	193 2.2×	16	582
Andrea Kopp Lugli Switzerland	11	156 0.5×	67 0.5×	169 1.2×	82 0.7×	69 0.8×	27	602
Elias N. Glaros Australia	16	204 0.7×	76 0.6×	395 2.9×	58 0.5×	52 0.6×	23	724
Ken Mizuno Japan	13	77 0.2×	37 0.3×	247 1.8×	42 0.3×	46 0.5×	26	640
Danielle L. McLean United States	11	234 0.7×	94 0.7×	330 2.4×	206 1.7×	131 1.5×	12	770
Anna Pezzatini Italy	12	167 0.5×	400 2.9×	204 1.5×	27 0.2×	50 0.6×	13	684
Eirini I. Bimpaki United States	9	136 0.4×	109 0.8×	283 2.1×	118 1.0×	112 1.3×	12	524
Kexin Meng China	14	79 0.3×	63 0.5×	210 1.5×	155 1.3×	12 0.1×	31	584

Countries citing papers authored by Valentin Blanchard

Since Specialization

Citations

This map shows the geographic impact of Valentin Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentin Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentin Blanchard more than expected).

Fields of papers citing papers by Valentin Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentin Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentin Blanchard. The network helps show where Valentin Blanchard may publish in the future.

Co-authorship network of co-authors of Valentin Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Valentin Blanchard. A scholar is included among the top collaborators of Valentin Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentin Blanchard. Valentin Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blanchard, Valentin, et al.. (2025). Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review. Diabetes & Metabolism. 51(5). 101683–101683.

Ying, Qidi, Dick C. Chan, Jing Pang, et al.. (2023). Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia. Clinical Nutrition ESPEN. 55. 174–177. 2 indexed citations

Bobin‐Dubigeon, Christine, Hassan Nazih, Valentin Blanchard, Mikaël Croyal, & Jean‐Marie Bard. (2022). Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity. Journal of Clinical Medicine. 11(5). 1345–1345. 4 indexed citations

Croyal, Mikaël, Matthieu Wargny, Kévin Chemello, et al.. (2022). Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes. Cardiovascular Diabetology. 21(1). 21–21. 16 indexed citations

Blanchard, Valentin, et al.. (2022). Smooth Muscle Cell—Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location. Frontiers in Physiology. 13. 921597–921597. 34 indexed citations

Blanchard, Valentin, et al.. (2022). Lysosomal acid lipase deficiency: A rare inherited dyslipidemia but potential ubiquitous factor in the development of atherosclerosis and fatty liver disease. Frontiers in Genetics. 13. 1013266–1013266. 11 indexed citations

Chemello, Kévin, Dirk Blom, A. David Marais, Gilles Lambert, & Valentin Blanchard. (2022). Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms. Current Atherosclerosis Reports. 24(6). 399–405. 1 indexed citations

Ying, Qidi, Mikaël Croyal, Dick C. Chan, et al.. (2022). Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 30(3). 274–286. 2 indexed citations

Ramin‐Mangata, Stéphane, Aurélie Thedrez, Brice Nativel, et al.. (2021). Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function. Atherosclerosis. 326. 47–55. 20 indexed citations

10.

Saulnier, Pierre‐Jean, Louis Potier, Mikaël Croyal, et al.. (2021). Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study. Diabetologia. 64(3). 668–680. 18 indexed citations

11.

Blanchard, Valentin, Kévin Chemello, Tim Hollstein, et al.. (2021). The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors. Cardiovascular Research. 118(9). 2103–2111. 20 indexed citations

12.

Chemello, Kévin, Sandra Beeské, Thi Thu Trang Tran, et al.. (2020). Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab. JACC Basic to Translational Science. 5(6). 549–557. 19 indexed citations

13.

Croyal, Mikaël, Valentin Blanchard, Khadija Ouguerram, et al.. (2020). VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly. Arteriosclerosis Thrombosis and Vascular Biology. 40(3). 819–829. 25 indexed citations

14.

Blanchard, Valentin, Kévin Chemello, Stéphanie Billon‐Crossouard, et al.. (2020). A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins. Journal of Lipid Research. 61(7). 1128–1139. 28 indexed citations

15.

Ramin‐Mangata, Stéphane, Matthieu Wargny, Matthieu Pichelin, et al.. (2019). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis. 293. 49–56. 17 indexed citations

16.

Croyal, Mikaël, Jean-Christophe Le Bail, Elise F. Villard, et al.. (2018). PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. Clinical Science. 132(10). 1075–1083. 35 indexed citations

17.

Blanchard, Valentin, et al.. (2018). PCSK9: from biology to clinical applications. Pathology. 51(2). 177–183. 37 indexed citations

18.

Blanchard, Valentin, Stéphane Ramin‐Mangata, Stéphanie Billon‐Crossouard, et al.. (2018). Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study. Journal of Lipid Research. 59(5). 892–900. 28 indexed citations

19.

Ramin‐Mangata, Stéphane, Valentin Blanchard, & Gilles Lambert. (2018). Key aspects of PCSK9 inhibition beyond LDL lowering. Current Opinion in Lipidology. 29(6). 453–458. 7 indexed citations

20.

Thedrez, Aurélie, Dirk Blom, Stéphane Ramin‐Mangata, et al.. (2017). Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor). Arteriosclerosis Thrombosis and Vascular Biology. 38(3). 592–598. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact